Life Sciences: What's new?

February 07, 2024

Read more about the recent developments in the life sciences sector.

Content :

Antitrust: Pharmaceutical Antitrust: An Analysis of US and EU Law
Regulatory: Court Affirms CEPS’ Pricing Power
Intellectual Property: Unitary Supplementary Protection Certificate: A Step Toward Coherent European Protection of Intellectual Property?
Antitrust: Pharma deals: the EU and US antitrust agencies order Illumina and GRAIL to unwind their merger
Regulatory: A(nother) Year Managing Shortages of Pharmaceutical Products
Antitrust: Teva/Cephalon patent settlement case: the General Court upholds the Commission’s “pay-for-delay” decision.